Loader

Ion Torrent™ Oncomine™ Pan-Cancer Cell-Free Assay

On demand
Brand origin : United States
Expiry time : On demand
Delivery time : 1 Week/s
Delivery cost : On demand
Unit size : 8 Reactions
Order number : A37664
(Ex-work price)
$ On demand

Ion Torrent™ Oncomine™ Pan-Cancer Cell-Free Assay

 

The Oncomine Pan-Cancer Cell-Free Assay is part of a complete solution to detect multiple targets in tumor-derived DNA and RNA isolated from the plasma fraction of whole blood. The assay provides the reagents and a single pool of multiplex PCR primers for preparation of an amplicon library from cell-free total nucleic acid (cfTNA) obtained from the plasma fraction of a single 10-mL tube of whole blood. This library can then be used for highly multiplexed targeted next-generation sequencing (NGS). 

The 52-gene panel includes: 

  • Hotspot genes (SNVs) and short indels: AKT1, ALK, AR, ARAF, BRAF, CHEK2, CTNNB1, DDR2,EGFR, ERBB2, ERBB3, ESR1, FGFR1, FGFR2, FGFR3, FGFR4, FLT3, GNA11, GNAQ, GNAS, HRAS, IDH1, IDH2, KIT, KRAS, MAP2K1, MAP2K2, MET, MTOR, NRAS, NTRK1, NTRK3, PDGFRA, PIK3CA, RAF1, RET, ROS1, SF3B1, SMAD4, SMO 
  • Gene fusions: ALK, BRAF, ERG, ETV1, FGFR1, FGFR2, FGFR3, MET, NTRK1, NTRK3, RET, ROS1 
  • MET exon 14 skipping 
  • Copy number genes (CNVs): CCND1, CCND2, CCND3, CDK4, CDK6, EGFR, ERBB2, FGFR1, FGFR2, FGFR3, MET, MYC 
  • Tumor suppressor genes: APC, FBXW7, PTEN, TP53 

These genes have been identified as frequently mutated in multiple cancer types, including: bladder, brain and CNS, breast, cervical, colorectal, endometrial, esophageal, gastric, head and neck, kidney, liver, lung, melanoma, ovarian, pancreatic, prostate, sarcoma, and thyroid. 

 

Features 

  • From a single tube of blood, generates an amplicon library from both DNA and RNA with a detection limit of 0.1% for SNVs
  • Amplicon size optimized for short cfDNA, ensuring highest possible capture rate 
  • Tag Sequencing technology minimizes false positives by removing randomly incorporated errors 
  • Optimized targeted assay design allows highly multiplexed NGS, reducing sequencing costs per sample
  • Two-day workflow from single 10-mL tube of blood to report; total time to targeted libraries is just four hours 
  • Enables cancer genetic studies from just 5 ng of input cfTNA
  • Compatible with FFPE samples for possible concordance studies 

 

Contents 

  • 1 x 16 µL Pan-Cancer cfTNA Panel
  • 1 x 320 µL cfDNA Library PCR Master Mix
  • 1 x 832 µL Low TE Buffer
  • 1 x 8 µL cfDNA Library Primer P1 
  • 1 x 8 µL cfDNA Library Primer A/BC1 
  • 1 x 22 µL SuperScript VILO MasterMix

 

 

 


 

More  

There are no report


You May Also Like